-
Product Name
Human CCL5/RANTES recombinant protein
- Documents
-
Description
Chemokines are a family of small chemotactic cytokines, or proteins secreted by cells. Chemokines share the same structure similarities such as small size, and the presence of four cysteine residues in conserved locations in order to form their 3-dimensional shape. Some of the chemokines are considered pro-inflammatory which can be induced to recruit cells of the immune system to a site of infection during an immune response, while others are considered homeostatic and are implied in controlling the migration of cells during normal processes of tissue maintenance and development. There are four members of the chemokine family: C-C kemokines, C kemokines, CXC kemokines and CX3C kemokines. The C-C kemokines have two cysteines nearby the amino terminus. There have been at least 27 distinct members of this subgroup reported for mammals, called C-C chemokine ligands-1 to 28. Chemokin ligand 5(CCL5) is chemotactic for T cells, basophils and eosinophils. Chemokin ligand 5(CCL5) has been considered a HIV-supressor secreted by CD8+ T cells and other immune cells. Chemokin ligand 5(CCL5) is a key to activating recruit leukocytes into inflammatory sites and in the presence of particular cytokines released by T cells, it can change the NK cells into CHAK cells.
-
Protein name
C-C motif chemokine
-
Protein short names
MURANTES; SISD; EOCP; SCYA5; MGC17164; D17S136E; RANTES; TCP228; SIS-DELTA; CCL5
-
Uniprot ID
P13501
-
Gene Name
CCL5; hCG_32592
-
Source/Expression Host
E. coli
-
Expression Plasmid/cDNA
A DNA sequence encoding the human CCL5 (NP_002976.2) (Ser24-Ser91) was expressed with an initial Met.
-
Protein Species
Human
-
Molecular weight
The recombinant human CCL5 consists 69 amino acids and predicts a molecular mass of 8 kDa.
-
Purity
> 95 % as determined by SDS-PAGE.
-
Validations
Human CCL5 / RANTES Protein
Related Products / Services
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"